Loading...
XTAI4148
Market cap89mUSD
Dec 20, Last price  
45.40TWD
1D
-0.33%
1Q
-4.82%
IPO
-37.89%
Name

All Cosmos Bio-Tech Holding Corp

Chart & Performance

D1W1MN
XTAI:4148 chart
P/E
20.86
P/S
1.03
EPS
2.18
Div Yield, %
5.51%
Shrs. gr., 5y
1.95%
Rev. gr., 5y
1.01%
Revenues
2.83b
-23.65%
1,404,531,0001,804,681,0001,874,852,0002,231,231,0002,257,308,0002,065,543,0002,263,652,0002,687,581,0001,767,699,0001,642,783,0002,197,323,0003,702,330,0002,826,587,000
Net income
139m
-62.15%
162,321,000210,360,000158,476,000195,639,000197,064,000243,217,000322,873,000305,058,00035,694,00082,204,000198,128,000368,204,000139,361,000
CFO
959m
+2,087.90%
138,047,000194,852,00041,583,00097,034,000145,766,000507,381,000176,120,000-218,333,000883,558,000-126,878,000-67,643,00043,843,000959,243,000
Dividend
Jul 11, 20241 TWD/sh

Profile

All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In addition, the company is involved in the research and forest plantation activities. It also exports its products to Taiwan, Indonesia, Vietnam, and China. All Cosmos Bio-Tech Holding Corporation was founded in 1999 and is headquartered in George Town, the Cayman Islands.
URL
https://www.allcosmos.com/en/
IPO date
Jun 08, 2017
Employees
Domiciled in
MY
Incorporated in
KY

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,826,587
-23.65%
3,702,330
68.49%
2,197,323
33.76%
Cost of revenue
2,638,691
3,042,599
1,984,588
Unusual Expense (Income)
NOPBT
187,896
659,731
212,735
NOPBT Margin
6.65%
17.82%
9.68%
Operating Taxes
68,321
177,931
84,931
Tax Rate
36.36%
26.97%
39.92%
NOPAT
119,575
481,800
127,804
Net income
139,361
-62.15%
368,204
85.84%
198,128
141.02%
Dividends
(160,085)
(96,051)
(64,034)
Dividend yield
4.58%
2.71%
2.49%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
513,206
406,641
310,811
Long-term debt
39,728
540,132
2,171
Deferred revenue
533,821
(28,771)
Other long-term liabilities
669
(533,821)
28,771
Net debt
(1,126,438)
(424,901)
(440,993)
Cash flow
Cash from operating activities
959,243
43,843
(67,643)
CAPEX
(162,750)
(60,859)
(103,848)
Cash from investing activities
(202,979)
(4,668)
(108,167)
Cash from financing activities
(549,882)
490,389
196,099
FCF
728,163
(80,555)
(198,542)
Balance
Cash
1,657,029
1,468,195
930,133
Long term investments
22,343
(96,521)
(176,158)
Excess cash
1,538,043
1,186,558
644,109
Stockholders' equity
1,890,287
2,087,245
1,602,669
Invested Capital
1,819,910
2,561,538
2,017,858
ROIC
5.46%
21.04%
7.07%
ROCE
5.53%
17.46%
7.91%
EV
Common stock shares outstanding
70,766
66,041
64,207
Price
49.35
-8.10%
53.70
33.92%
40.10
3.08%
Market cap
3,492,302
-1.53%
3,546,402
37.74%
2,574,701
3.23%
EV
2,925,715
3,617,777
2,521,975
EBITDA
237,043
708,743
261,327
EV/EBITDA
12.34
5.10
9.65
Interest
3,983
18,810
4,537
Interest/NOPBT
2.12%
2.85%
2.13%